QA: Arqule INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001019695_2019_Arqule_INC.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001019695, Arqule INC

  xvar xval
0 AssetsCurrent 106,403,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 69,000
3 remainder_Assets 204,000
4 LiabilitiesCurrent 14,615,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 13,093,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,995,518
9 ResearchAndDevelopmentExpense 27,346,504
10 remainder_Expenses 1,666,225
11 remainder_Revenues 0
12 remainder_NetIncome 23,206,688
13 remainder_ComprehensiveNetIncome -64,489
  yvar yval
0 Assets 106,676,000
1 Liabilities 27,708,000
2 Expenses 40,008,247
3 Revenues 0
4 StockholdersEquity 78,968,000
5 NetIncome -16,801,559
6 ComprehensiveNetIncome -16,833,804
7 BaseVar 98,831,712
8 EconomicCapitalRatiobeforeLimitedLiability 2.31
9 EconomicCapitalRatio 3.23

Edgar->Model Mapping

Feature Distribution

Change over Time